Neuracle Science Co., Ltd.
USPTO PatentsView assignee record - 17 granted patents across 7 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Neuracle ranks #17,028 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 7 technology areas.
- #17,028
- of 49,997 US assignees by volume
- Top 13%
- by Innovation Score (50.2/100)
- 18.2
- avg claims per patent
- +500%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17028 · Foreign Corporation #17,028 · 17 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 17 grants
- MID-PACK #17,028/49,997
- PHOTO-FINISH Nano Intelligent…
- CPC-NARROW A61P · 7 areas
- INNOV-PAR 50.2/100
- CLAIMS-RICH 18.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +500% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Nano Intelligent Biomedical Engineering Corporation Co. Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Neuracle’s 50.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Neuracle
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Neuracle Science · this assignee
Neuracle Science · this assignee
50 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Neuracle's Innovation Score is 50.2/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Neuracle?
Each dot is one of Neuracle’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neuracle’s own 18.2 claims/patent is ABOVE the 16.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Neuracle's grants concentrate
Neuracle Science Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2017. By volume, Neuracle sits between Nano Intelligent Biomedical Engineering Corporation Co. Ltd. and NEX Services North America LLC.
Neuracle's three-year grant acceleration
Neuracle Science Co., Ltd. shows 10 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Neuracle's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nano Intelligent…
Nano Intelligent Biomedical Engineering Corporation Co. Ltd.
17 patents
- National Associat…
National Association FOR Stock CAR Auto Racing, LLC
17 patents
- Neograf Solutions
Neograf Solutions, LLC
17 patents
- Neuboron Therapy…
Neuboron Therapy System Ltd.
17 patents
- Neuro Kinetics
Neuro Kinetics, Inc.
17 patents
- Neuspera Medical
Neuspera Medical Inc.
17 patents
- NEW Power Plasma
NEW Power Plasma Co., Ltd.
17 patents
- NEX Services Nort…
NEX Services North America LLC
17 patents
- Neuracle Science ◀
Neuracle Science Co., Ltd.
17 patents
What this shows Neuracle holds 17 patents at rank #17,015, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Neuracle
By rank, the assignees closest to #17,015 in granted patent volume.
- Nano Intelligent Biomedical Engineering Corporation Co. Ltd. #17,011 · 17 patents
- National Association FOR Stock CAR Auto Racing, LLC #17,012 · 17 patents
- Neograf Solutions, LLC #17,013 · 17 patents
- Neuboron Therapy System Ltd. #17,014 · 17 patents
- Neuro Kinetics, Inc. #17,016 · 17 patents
- Neuspera Medical Inc. #17,017 · 17 patents
- NEW Power Plasma Co., Ltd. #17,018 · 17 patents
- NEX Services North America LLC #17,019 · 17 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Neuracle's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Neuracle's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
50 Top 13% higher than 87% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 5.9% |
| 2019 | 1 | 5.9% |
| 2020 | 1 | 5.9% |
| 2021 | 1 | 5.9% |
| 2022 | 2 | 11.8% |
| 2023 | 5 | 29.4% |
| 2024 | 3 | 17.6% |
| 2025partial year | 3 | 17.6% |
Which technologies does Neuracle Science Co., Ltd. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Neuracle Science Co., Ltd.'s patent record in context - here's where to go next.
- Neuracle Science Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #17,028 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Neuracle Science Co., Ltd. against Nano Intelligent Biomedical Engineering Corporation Co. Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 50.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.